Position in SMMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,208,022
+$1,888,122 QoQ
Shares Held
220,180
+216.3% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
2.24%
of 13F equity value
Holder Rank
#54
of 242 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in SMMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SECTORAL ASSET MANAGEMENT INC holds $69,797,747 across 47 Biotechnology names. SMMT ranks #6 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CTNM |
Contineum Therapeutics, Inc.
|
727,587 | $11,925,150 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
41,987 | $3,995,902 | |
| 3 | BNTX |
BioNTech SE
|
41,869 | $3,895,910 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
78,310 | $3,683,702 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
110,870 | $3,418,122 | |
| 6 | SMMT |
Summit Therapeutics Inc.
This page
|
220,180 | $3,208,022 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
79,043 | $2,745,953 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,432 | $2,698,237 |
All Filings in SMMT
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,208,022 | 220,180 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,319,900 | 69,615 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,392,641 | 79,625 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,530,286 | 74,070 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,387,881 | 65,220 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,335,639 | 69,240 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $535,350 | 30,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $584,730 | 26,700 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $195,000 | 25,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,304,100 | 315,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $78,300 | 30,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $37,400 | 20,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $125,500 | 50,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $35,000 | 20,000 | Shares | Sole | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||